ArticleClinical and translational science2023

Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants.

Sibel Ucpinar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.